Abstract:CREG1 (cellular repressor of E1A-stimulated genes 1) is involved in tissue homeostasis and influences macroautophagy/autophagy to protect cardiovascular function. However, the physiological and pathological role of CREG1 in the skeletal muscle is not clear. Here, we established a skeletal muscle-specific creg1 knockout mouse model (creg1;Ckm-Cre) by crossing the Creg1-floxed mice (Creg1fl/fl) with a transgenic line expressing Cre recombinase under the muscle-specific Ckm (creatine kinase, muscle) promoter. In creg1;Ckm-Cre mice, the exercise time to exhaustion and running distance were significantly reduced compared to Creg1fl/fl mice at the age of 9 months. In addition, the administration of recombinant (re)CREG1 protein improved the motor function of 9-month-old creg1;Ckm-Cre mice. Moreover, electron microscopy images of 9-month-old creg1;Ckm-Cre mice showed that the mitochondrial quality and quantity were abnormal and associated with increased levels of PINK1 (PTEN induced putative kinase 1) and PRKN/PARKIN (parkin RBR E3 ubiquitin protein ligase) but reduced levels of the mitochondrial proteins PTGS2/COX2, COX4I1/COX4, and TOMM20. These results suggested that CREG1 deficiency accelerated the induction of mitophagy in the skeletal muscle. Mechanistically, gain-and loss-of-function mutations of Creg1 altered mitochondrial morphology and function, impairing mitophagy in C2C12 cells. Furthermore, HSPD1/HSP60 (heat shock protein 1) (401–573 aa) interacted with CREG1 (130–220 aa) to antagonize the degradation of CREG1 and was involved in the regulation of mitophagy. This was the first time to demonstrate that CREG1 localized to the mitochondria and played an important role in mitophagy modulation that determined skeletal muscle wasting during the growth process or disease conditions.Abbreviations: CCCP: carbonyl cyanide m-chlorophenylhydrazone; CKM: creatine kinase, muscle; COX4I1/COX4: cytochrome c oxidase subunit 4I1; CREG1: cellular repressor of E1A-stimulated genes 1; DMEM: dulbecco's modified eagle medium; DNM1L/DRP1: dynamin 1-like; FCCP: carbonyl cyanide p-trifluoro-methoxy phenyl-hydrazone; HSPD1/HSP60: heat shock protein 1 (chaperonin); IP: immunoprecipitation; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; MFF: mitochondrial fission factor; MFN2: mitofusin 2; MYH1/MHC-I: myosin, heavy polypeptide 1, skeletal muscle, adult; OCR: oxygen consumption rate; OPA1: OPA1, mitochondrial dynamin like GTPase; PINK1: PTEN induced putative kinase 1; PPARGC1A/PGC-1α: peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; PRKN/PARKIN: parkin RBR E3 ubiquitin protein ligase; PTGS2/COX2: prostaglandin-endoperoxide synthase 2; RFP: red fluorescent protein; RT-qPCR: real-time quantitative PCR; SQSTM1/p62: sequestosome 1; TFAM: transcription factor A, mitochondrial; TOMM20: translocase of outer mitochondrial membrane 20; VDAC: voltage-dependent anion channel.

A Novel Function of CREG in Metabolic Disorders

The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance

The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes

CREG: a possible candidate for both prevention and treatment of proliferative vascular disease.

Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis.

CREG1 ameliorates myocardial fibrosis associated with autophagy activation and Rab7 expression.

CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance

CREG1 improves the capacity of the skeletal muscle response to exercise endurance via modulation of mitophagy

DNA Hypermethylation: A Novel Mechanism of CREG Gene Suppression and Atherosclerogenic Endothelial Dysfunction.

The Role of CREG1 in Megakaryocyte Maturation and Thrombocytopoiesis.

CREG1 promotes uncoupling protein 1 expression and brown adipogenesis in vitro

CREG Protects from Myocardial Ischemia/reperfusion Injury by Regulating Myocardial Autophagy and Apoptosis.

Overexpression of CREG Attenuates Atherosclerotic Endothelium Apoptosis Via VEGF/PI3K/AKT Pathway.

Cell Metabolism Role of CREB in Obesity active

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions

A Key Transcription Factor in the Regulation of Energy Metabolism at an Organismic Level and a Target of the ABA/LANCL Hormone Receptor System

CRTCs:an Essential Coactivator Family of CREB Regulated Transcription

CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders